JP Patent

JP6023062B2 — 置換ピリダジンカルボキサミド化合物

Assigned to エックスカバリー ホールディング カンパニー エルエルシー · Expires 2016-11-09 · 10y expired

What this patent protects

Patent listed against ensartinib-hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
JP6023062B2
Jurisdiction
JP
Classification
—
Expires
2016-11-09
Drug substance claim
No
Drug product claim
No
Assignee
エックスカバリー ホールディング カンパニー エルエルシー
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.